Category Archives: Cancer and neoplasms

New York, USA, Sept. 20, 2023 (GLOBE NEWSWIRE) — Osteosarcoma Market to Grow Rapidly by 2032, Assesses DelveInsight | Leading Companies – MedPacto, Y-mAbs, QSAM, BioEclipse, Cellectar Biosciences, BioAtla, Salarius, Jazz, Fusion, Sumitomo Pharma Oncology The dynamics of the osteosarcoma market are anticipated to change in the coming years owing to the improvement in the […]

Uwe Platzbecker, MD Data from ongoing phase 3 clinical trials could continue to alter the treatment landscape for patients with lower-risk myelodysplastic neoplasms (MDS), according to Uwe Platzbecker, MD. In an interview with OncLive®, Platzbecker, a professor of hematology and director of Medical Clinic I at the University Hospital of Leipzig in Germany, discussed these […]

New York, USA, Sept. 19, 2023 (GLOBE NEWSWIRE) — Diffuse Large B-cell Lymphoma Market to Show Immense Growth by 2032, Predicts DelveInsight | Leading Players to Look Out – AbbVie, Genmab, Merck, Xencor, Janssen, Roche, Biogen, Regeneron, Seagen, Takeda The DLBCL market has a diverse pipeline, with the emergence of novel classes such as bi-specific […]

Specialty

“ALYCANTE is the first study to assess [axi-cel] as second-line therapy for transplant ineligible R/R LBCL and the results showed high response rates and durable remission in this hard-to-treat population,” according to Roch Houot, professor and head of the Haematology Department at University Hospital of Rennes, France. Treatment with axicabtagene ciloleucel (Axi-cel; Yescarta) produced high […]

The FDA approved ruxolitinib as a treatment for patients with polycythemia vera who are intolerant to hydroxyurea in December 2014. The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending the approval of ruxolitinib (Jakafi) as a treatment for adult patients with polycythemia vera that is intolerant or resistant […]

Here are 16 gastroenterology updates Becker’s has reported on since Aug. 25: 1. The Digestive Health Physicians Association issued a statement of support for the proposed Protecting Patient Access to Cancer Care and Complex Therapies act, introduced by three Republican senators and representatives.  2. U.S. Digestive Health partnered with Wilmington-based GI Specialists of Delaware. 3. […]

Specialty